ACIP recommendation for COVID booster for children

Translate to Spanish or other 102 languages!

“We applaud the Advisory Committee on Immunization Practices (ACIP) for their thoughtful deliberations and recommendation supporting that children ages 5-11 should receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine, at least five months after completion of the primary series. Image or illustration purposes
“We applaud the Advisory Committee on Immunization Practices (ACIP) for their thoughtful deliberations and recommendation supporting that children ages 5-11 should receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine, at least five months after completion of the primary series. Image or illustration purposes

Mega Doctor News

- Advertisement -
Gerald E. Harmon, MD
President, American Medical Association
Courtesy Image

The following statement is attributable to:
Gerald E. Harmon, MD
President, American Medical Association

“We applaud the Advisory Committee on Immunization Practices (ACIP) for their thoughtful deliberations and recommendation supporting that children ages 5-11 should receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine, at least five months after completion of the primary series. Based on what we know from other age groups, vaccine effectiveness against SARS-CoV-2 infection declines over time and vaccine booster doses have been shown to increase protection against all outcomes. With the highly transmissible Omicron variant continuing to evolve, strengthened neutralizing antibodies from the booster dose provides an additional layer of protection.

“The scientific evidence is clear that the vaccines against COVID-19 are safe and remain effective in preventing hospitalization and severe disease. It is concerning that only one in three children between the ages of 5 and 11 in the United States have received two doses of the vaccine, in part because parents believe them to be at lower risk for severe disease than adults. But the Omicron variant brought about change that should alter that calculus. According to the Centers for Disease Control and Prevention (CDC), the highly transmissible variant not only sent more children to the hospital and ICU than previous waves, but children who were unvaccinated were twice as likely to be hospitalized as those were vaccinated.

- Advertisement -

“Against this backdrop, we continue to strongly urge those who are eligible to stay up to date on their COVID-19 vaccines, including booster doses, to protect themselves and their loved ones from severe complications, hospitalization, and death. We look forward to the deliberations of the FDA’s Vaccines and Related Biological Products Advisory Committee and the ACIP on COVID-19 vaccine for kids under the age of 5, as many families are anxiously awaiting a safe and effective vaccine for this population.”

“Anyone with questions about the vaccines should speak with their physician and review trusted resources, including getvaccineanswers.org.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

What to Know About the Cyclospora Parasite in Your Grocery Cart

You’ve probably seen the headlines about a parasite spreading across the United States and making people sick, but what exactly is causing it? 

STHS Children’s Free Food Safety Webinar for Parents on July 15th

Every meal should help children grow and thrive, not put their health at risk.

How Extreme Weather and Air Pollution Put Your Heart at Risk

It’s not just high temperatures that can put stress on the heart. Other environmental factors, such as air pollution, extreme cold, hurricanes, wildfires, and other climate events, can contribute to or worsen cardiovascular conditions.

Scientists Unlock Faster, Better Way to Capture Ultimate Cancer-Fighting Cells

A new platform developed by researchers at The University of Texas MD Anderson Cancer Center quickly finds and isolates rare, tumor-reactive immune cells that are especially good at recognizing and attacking cancer cells, even without knowing which tumor targets are recognized by the immune cells. This approach addresses a major bottleneck in immunotherapy development and could potentially accelerate the creation of personalized treatments.
- Advertisement -